Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Adjunctive inspiratory muscle training during a rehabilitation program in patients with breast cancer: an exploratory double-blind, randomized, controlled pilot study
Dahhak A, Devoogdt N, Langer D
Archives of Rehabilitation Research and Clinical Translation 2022 Jun;4(2):100196
clinical trial
9/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: Yes; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

OBJECTIVE: To investigate whether inspiratory muscle training (IMT) offered adjunctively to an exercise training program reduces symptoms of dyspnea in survivors of breast cancer. DESIGN: Double-blind, parallel-group, randomized controlled trial. SETTINGS: Outpatient rehabilitation program in a university hospital. PARTICIPANTS: Ninety-eight female patients with breast cancer who completed adjuvant treatment and subsequently entered cancer rehabilitation were screened for participation. Inclusion criteria were reduced inspiratory muscle strength and/or symptoms of dyspnea. Twenty patients (N = 20) were randomly assigned to an intervention group (n = 10) or a control group (n = 10). INTERVENTIONS: Both groups received a 3-month exercise training program in combination with either IMT (intervention) or sham-IMT (control). MAIN OUTCOME MEASURES: Changes in dyspnea intensity perception (10-point Borg Scale) at comparable time points (isotime) during constant work rate cycling was the primary outcome. Secondary outcomes included changes in respiratory muscle function, exercise capacity, and changes in symptoms of dyspnea during daily life (Transitional Dyspnea Index (TDI)). RESULTS: The intervention group achieved a larger reduction in exertional dyspnea at isotime compared with the control group (-1.8 points; 95% CI -3.7 to 0.13; p = 0.066). The intervention group also exhibited larger improvements in dyspnea during daily life (TDI score, +2.9 points; 95% CI 0.5 to 5.3; p = 0.022) and improved both respiratory muscle endurance (+472 seconds; 95% CI 217 to 728; p = 0.001) and cycling endurance (+428 seconds; 95% CI 223 to 633; p = 0.001) more than the control group. CONCLUSIONS: Because of the limited sample size all obtained findings need to be interpreted with caution. The study offers initial insights into the potential of adjunctive IMT in selected survivors of breast cancer. Larger multicenter studies should be performed to further explore the potential role and general acceptance of this intervention as a rehabilitation tool in selected patients after breast cancer treatment.

Full text (sometimes free) may be available at these link(s):      help